In this IP Law360 article, Paul A. Calvo, Ph.D. and Eldora L. Ellison, Ph.D. discuss potential challenges facing biosimilar developers and the importance of post-grant patent challenges at the U.S. Patent and Trademark Office as a mechanism for obtaining early and fast patent certainty.
To read the full article, download the attached PDF.
Related Industries
Related Services
![Post-Grant Proceedings Are Important For Biosimilars](https://www.sternekessler.com/app/themes/sternekessler/dist/images/0.gif)
Stay in the Know
Receive insights from the most respected practitioners of IP law, straight to your inbox.
Subscribe for Updates![](https://www.sternekessler.com/app/uploads/2023/05/subscribe-cta.png)